ArticleActa oncologica (Stockholm, Sweden)2022

Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer.

Grete May Engeseth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.